UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis

PLoS pathogens, 2019-06, Vol.15 (6), p.e1007796

2019

Volltextzugriff (PDF)

Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFNβ expression

The Journal of biological chemistry, 2024-09, Vol.300 (9), p.107645, Article 107645

2024

Volltextzugriff (PDF)

Epstein–Barr virus latent genes

Experimental & molecular medicine, 2015-01, Vol.47 (1), p.e131-e131

2015

Volltextzugriff (PDF)

Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait

Immunity (Cambridge, Mass.), 2022-01, Vol.55 (1), p.174-184.e5

2022

Volltextzugriff (PDF)

Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells

Journal of virology, 2018-10, Vol.92 (19)

2018

Volltextzugriff (PDF)

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice

PLoS pathogens, 2024-04, Vol.20 (4), p.e1012132-e1012132

2024

Volltextzugriff (PDF)

EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells

Proceedings of the National Academy of Sciences - PNAS, 2022-07, Vol.119 (30), p.e2200512119

2022

Volltextzugriff (PDF)

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice

PLoS pathogens, 2020-06, Vol.16 (6), p.e1008590

2020

Volltextzugriff (PDF)

Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus oriP

Journal of virology, 2022-09, Vol.96 (17), p.e0094922-e0094922

2022

Volltextzugriff (PDF)

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

Journal of clinical oncology, 2013-01, Vol.31 (1), p.39-48

2013

Volltextzugriff (PDF)

Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency

The Journal of biological chemistry, 2010-10, Vol.285 (43), p.33358-33370

2010

Volltextzugriff (PDF)

Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance

Cell, 2021-02, Vol.184 (3), p.643-654.e13

2021

Volltextzugriff (PDF)

A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism

PLoS pathogens, 2021-01, Vol.17 (1), p.e1009208

2021

Volltextzugriff (PDF)

Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival

PLoS pathogens, 2019-09, Vol.15 (9), p.e1008030-e1008030

2019

Volltextzugriff (PDF)

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth

Proceedings of the National Academy of Sciences - PNAS, 2011-09, Vol.108 (36), p.14902-14907

2011

Volltextzugriff (PDF)

Characterization of a cancer-associated Epstein-Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3

Virology (New York, N.Y.), 2021-10, Vol.562, p.103-109

2021

Volltextzugriff (PDF)

Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus

Proceedings of the National Academy of Sciences - PNAS, 2018-11, Vol.115 (48), p.E11379-E11387

2018

Volltextzugriff (PDF)

Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming

PLoS pathogens, 2013-09, Vol.9 (9), p.e1003636-e1003636

2013

Volltextzugriff (PDF)

An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation

PLoS pathogens, 2017-07, Vol.13 (7), p.e1006500-e1006500

2017

Volltextzugriff (PDF)

The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization

Journal of virology, 2020-08, Vol.94 (17)

2020

Volltextzugriff (PDF)

Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

BMC genomics, 2024-03, Vol.25 (1), p.273-273, Article 273

2024

Volltextzugriff (PDF)

EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner's lesion

The Journal of pathology, 2023-03, Vol.259 (3), p.276-290

2023

Volltextzugriff (PDF)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency

Oncotarget, 2017-01, Vol.8 (5), p.7248-7264

2017

Volltextzugriff (PDF)

Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA

Molecules (Basel, Switzerland), 2020-04, Vol.25 (7), p.1760

2020

Volltextzugriff (PDF)

Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication

Journal of virology, 2019-10, Vol.93 (20)

2019

Volltextzugriff (PDF)

1 – 25 von 746

Suche als RSS-Feed

Aktive Filter

ThemaEpstein-Barr Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(734)
Mit Volltextzugriff
(693)

Publikationsform

Artikel
(746)

Sprache

Englisch
(745)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(710)
Humans
(655)
Life Sciences & Biomedicine
(644)
Epstein-Barr Virus Nuclear Antigens - Metabolism
(374)
Virology
(338)
Herpesvirus 4, Human - Genetics
(316)
Epstein-Barr Virus Nuclear Antigens - Genetics
(271)
Biological And Medical Sciences
(212)
Cell Line
(197)
Herpesvirus 4, Human - Metabolism
(172)
Animals
(171)
Microbiology
(169)
Epstein-Barr Virus Nuclear Antigens
(154)
Herpesvirus 4, Human - Physiology
(153)
Fundamental And Applied Biological Sciences. Psychology
(148)
Biochemistry & Molecular Biology
(138)
Dna-Binding Proteins - Metabolism
(134)
Proteins
(133)
Molecular Sequence Data
(129)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis

Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFNβ expression

Epstein–Barr virus latent genes

Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait

Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice

EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice

Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus oriP

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency

Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance

A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism

Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth

Characterization of a cancer-associated Epstein-Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3

Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus

Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming

An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation

The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization

Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner's lesion

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency

Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA

Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication

Aktive Filter

Suchergebnisse filtern